Cargando…
13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation
BACKGROUND: The Paul-Ehrlich-Institut (PEI) published an analysis of reports of adverse drug reactions (ADRs) in 2001 with test and therapy allergens from the period from 1991 to 2000. Possible risk factors were evaluated for the ADR reports classified as “serious”. During the analyzed period, modif...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792348/ https://www.ncbi.nlm.nih.gov/pubmed/27069842 http://dx.doi.org/10.1007/s40629-015-0084-y |